Fatal thrombotic event after infusion of recombinant activated factor VII after cardiac surgery.
Pichon
N
N
Medical-Surgical Intensive Care Unit, Dupuytren Teaching Hospital, Limoges, France. nicolas.pichon@chu-limoges.fr
Bellec
F
F
Sekkal
S
S
Marsaud
J P
JP
Laskar
M
M
François
B
B
Vignon
P
P
D001011:Aorta / Q000601:surgery; D001021:Aortic Valve / Q000601:surgery; D001807:Blood Vessel Prosthesis; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002341:Carotid Artery Thrombosis / Q000139:chemically induced*; D003029:Coagulants / Q000009:adverse effects / Q000627:therapeutic use; D015942:Factor VIIa / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D006349:Heart Valve Diseases / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000209:etiology; D020521:Stroke / Q000209:etiology*; D017211:Treatment Failure
D003029:Coagulants; D015942:Factor VIIa